Transatlantique Private Wealth’s Icon ICLR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$733K Sell
4,022
-92
-2% -$16.4K 0.23% 122
2025
Q3
$720K Buy
4,114
+212
+5% +$35.5K 0.24% 116
2025
Q2
$568K Sell
3,902
-4
-0.1% -$567 0.21% 134
2025
Q1
$684K Sell
3,906
-2,808
-42% -$544K 0.27% 112
2024
Q4
$1.41M Buy
6,714
+503
+8% +$117K 0.54% 52
2024
Q3
$1.78M Sell
6,211
-800
-11% -$252K 0.68% 36
2024
Q2
$2.18M Buy
7,011
+153
+2% +$47.9K 0.89% 27
2024
Q1
$2.28M Buy
6,858
+70
+1% +$20.6K 1% 21
2023
Q4
$1.9M Sell
6,788
-635
-9% -$164K 0.89% 23
2023
Q3
$1.82M Buy
7,423
+36
+0.5% +$9.07K 0.97% 24
2023
Q2
$1.85M Buy
7,387
+70
+1% +$14.9K 0.96% 25
2023
Q1
$1.54M Buy
7,317
+1,497
+26% +$333K 0.85% 26
2022
Q4
$1.12M Buy
5,820
+313
+6% +$62.1K 0.67% 40
2022
Q3
$1.01M Buy
5,507
+391
+8% +$85.1K 0.68% 42
2022
Q2
$1.11M Buy
+5,116
New +$1.15M 0.77% 34

Other funds holding ICLR

Transatlantique Private Wealth's ICLR Position: Q4 2025 in Review

Transatlantique Private Wealth reduced its Icon (ICLR) stake by 2.2% in Q4 2025, selling an estimated $16.4K and leaving 4,022 shares worth $733K. The position accounts for 0.23% of the portfolio, ranked #122.

Transatlantique Private Wealth first reported a position in ICLR in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.28M in Q1 2024. 513 funds tracked by Wall St. Rank hold ICLR as of Q4 2025.

  • Transatlantique Private Wealth held 4,022 shares of Icon worth $733K as of Q4 2025.
  • Transatlantique Private Wealth sold 92 Icon shares in Q4 2025, an estimated $16.4K.
  • Icon made up 0.23% of Transatlantique Private Wealth's portfolio in Q4 2025, its #122 holding.
  • Transatlantique Private Wealth first reported a position in Icon in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's Icon position peaked at $2.28M in Q1 2024.
  • 513 funds tracked by Wall St. Rank held Icon as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.